Stay updated on Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial
Sign up to get notified when there's something new on the Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial page.

Latest updates to the Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial page
- Check7 days agoChange DetectedThe page now shows a new Revision: v3.6.6, replacing the previous Revision: v3.6.5. This appears to be a minor software version update with no visible changes to the study content or navigation.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedFooter revision updated from v3.6.4 to v3.6.5, representing a new site version. No visible content or behavior changes are introduced.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous Revision: v3.6.3. This represents a minor software/version update and does not alter the study content or displayed details.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page footer now shows a new revision tag, updating from v3.6.0 to v3.6.3. This is a minor metadata update and does not modify the study details, eligibility criteria, or results.SummaryDifference0.0%

- Check85 days agoChange DetectedThe page now indicates recruitment is closed and adds user-help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a revision update to v3.6.0. The old 'Intervention / Treatment' heading has been removed/renamed to 'Intervention/Treatment'.SummaryDifference0.3%

- Check92 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, indicating a minor update; this appears to be a version bump rather than a substantive content change.SummaryDifference0.0%

Stay in the know with updates to Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabotegravir+VRC-HIVMAB075 in HIV-1 Viral Suppression Clinical Trial page.